Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India. (November 2021)
- Record Type:
- Journal Article
- Title:
- Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India. (November 2021)
- Main Title:
- Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India
- Authors:
- Bhosale, Ramesh
Alexander, Mallika
Deshpande, Prasad
Kulkarni, Vandana
Gupte, Nikhil
Gupta, Amita
Mathad, Jyoti - Abstract:
- Highlights: Pregnancy stage and HIV status impacted results of tuberculosis infection tests. IFN γ response was lower in HIV+ women at pregnancy stages relative to HIV- women. IFN γ response was lowest at delivery for both HIV+ and HIV- women. IGRA/TST agreement was lower in HIV+ women than HIV- at pregnancy and delivery. HIV+ and IGRA-positive pregnant women are at high risk of TB post-partum Abstract: Background: Accurate tuberculosis infection (TBI) tests are critical for pregnant women, especially those with HIV, who have a high risk of TB disease. Methods: We enrolled interferon gamma release assay (IGRA)+ pregnant women with and without HIV in a longitudinal study, followed up at delivery and 6 months postpartum. Tuberculin skin test (TST) and IGRA were compared by HIV status at each timepoint. Results: Of 165 enrolled IGRA+ pregnant women: 35 (21%) had HIV and were on antiretroviral therapy with median CD4 of 476 (IQR 399–586). Compared to antepartum, significantly fewer women remained IGRA+ at delivery [HIV+ n=21/35 (62%, p=0.009); HIV- n=100/130 (77%, p=0.002)] and postpartum [HIV+ n=30/35 (87%, p=0.03); HIV– n=116/130 (89%, p=0.01)]. IGRA/TST discordance was high in pregnant women (HIV+: 51%; HIV-: 25%). Median IFN-γ was lowest for all women at delivery; significantly lower in women with HIV at all timepoints compared to women without HIV. TB incidence was 50/ 1000 person-years and 18/1000 person-years among women with and without HIV respectively. Conclusions:Highlights: Pregnancy stage and HIV status impacted results of tuberculosis infection tests. IFN γ response was lower in HIV+ women at pregnancy stages relative to HIV- women. IFN γ response was lowest at delivery for both HIV+ and HIV- women. IGRA/TST agreement was lower in HIV+ women than HIV- at pregnancy and delivery. HIV+ and IGRA-positive pregnant women are at high risk of TB post-partum Abstract: Background: Accurate tuberculosis infection (TBI) tests are critical for pregnant women, especially those with HIV, who have a high risk of TB disease. Methods: We enrolled interferon gamma release assay (IGRA)+ pregnant women with and without HIV in a longitudinal study, followed up at delivery and 6 months postpartum. Tuberculin skin test (TST) and IGRA were compared by HIV status at each timepoint. Results: Of 165 enrolled IGRA+ pregnant women: 35 (21%) had HIV and were on antiretroviral therapy with median CD4 of 476 (IQR 399–586). Compared to antepartum, significantly fewer women remained IGRA+ at delivery [HIV+ n=21/35 (62%, p=0.009); HIV- n=100/130 (77%, p=0.002)] and postpartum [HIV+ n=30/35 (87%, p=0.03); HIV– n=116/130 (89%, p=0.01)]. IGRA/TST discordance was high in pregnant women (HIV+: 51%; HIV-: 25%). Median IFN-γ was lowest for all women at delivery; significantly lower in women with HIV at all timepoints compared to women without HIV. TB incidence was 50/ 1000 person-years and 18/1000 person-years among women with and without HIV respectively. Conclusions: Pregnancy affects TBI test results and reduces IFN-γ response to M. tuberculosis stimulation. Despite adequate CD4 counts, women with HIV express less IFN-γ than women without HIV, which may explain the high TB incidence in postpartum women with HIV. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 112(2021)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 112(2021)
- Issue Display:
- Volume 112, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 112
- Issue:
- 2021
- Issue Sort Value:
- 2021-0112-2021-0000
- Page Start:
- 205
- Page End:
- 211
- Publication Date:
- 2021-11
- Subjects:
- Tubercular Infection (TBI) -- Interferon Gamma Release Assay (IGRA) -- Tuberculin Skin Test (TST) -- pregnancy, Human Immune Deficiency Virus (HIV) -- Interferon Gamma (IFN-γ)
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2021.09.010 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20076.xml